Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.


NDAQ:XXII - Post by User

Post by lelianicruzon Sep 27, 2024 1:35pm
29 Views
Post# 36244353

$XXII Sees Significant Trading Volume of 2.28 Million Shares

$XXII Sees Significant Trading Volume of 2.28 Million Shares

22nd Century Group, Inc. (NASDAQ: XXII) recently experienced a substantial trading volume, with 2,285,312 shares traded. This heightened activity reflects growing interest in the company’s innovative approach to tobacco products and nicotine reduction. As a leader in the tobacco industry, 22nd Century is gaining attention for its reduced-risk nicotine products, including its flagship VLN® cigarettes, which contain up to 95% less nicotine than traditional cigarettes.

The company has made notable progress with its expansion strategies, particularly with its Moonlight brand cigarettes in Southeast Asia and the launch of VLN® products in South Korea. These strategic moves have bolstered investor confidence, driving up trading volumes as the market anticipates further growth.

22nd Century’s mission to provide reduced-nicotine options to smokers aligns with global public health efforts aimed at minimizing smoking-related harm. With its unique FDA authorization for VLN® products and an aggressive market expansion plan, the company’s rising stock activity may signal increasing interest from both consumers and investors in the future of harm-reduction tobacco alternatives.

This surge in trading reflects the company’s potential for long-term success as it continues to innovate in the tobacco space.

<< Previous
Bullboard Posts
Next >>